Ainos

D

Quotes are delayed by 15 minutes

Sector: Healthcare

Industry: Medical Devices

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, andtelehealth-friendly POCTs powered by the AI Nose technology platform.